Innoprot provides products and technologies for multiplexing cell-based assays in drug discovery and development.
With a proprietary technology for GPCR screening, Innoprot is able to screen compounds analyzing both GPCR signalling pathways, measuring both G-Protein activation (cAMP, Ca, DAG) and b-arrestin recruitment in a single assay. Innoprot provide stable cell lines overexpressing label-free GPCR for multiplexing functional assays.
Innoprot also acts as a C.R.O. providing screening services focused on GPCRs, Fibrosis and Neurodegenerative diseases like Alzheimer's Disease, Parkinson's Disease or ALS.
Parque Tecnologico Bizkaia
Edificio 502, Primera Planta
Derio, 48160 Spain
34 94 400 5355